KEGG   PATHWAY: cimi05150
Entry
cimi05150                   Pathway                                
Name
Staphylococcus aureus infection - Cebus imitator (Panamanian white-faced capuchin)
Description
Staphylococcus aureus can cause multiple forms of infections ranging from superficial skin infections to food poisoning and life-threatening infections. The organism has several ways to divert the effectiveness of the immune system: secreting immune modulating proteins that inhibit complement activation and neutrophil chemotaxis or lysis, modulating the sensitivity to cationic antimicrobial peptides (such as defensin) by increasing the positive net charge of its cytoplasmic membrane, and expression of superantigens that prevent development of a normal immune response or cause an emetic response when ingested.
Class
Human Diseases; Infectious disease: bacterial
Pathway map
cimi05150  Staphylococcus aureus infection
cimi05150

Organism
Cebus imitator (Panamanian white-faced capuchin) [GN:cimi]
Gene
108281541  KRT39; keratin, type I cytoskeletal 39 [KO:K07604]
108299213  keratin, type I cuticular Ha1 [KO:K07604]
108299215  keratin, type I cuticular Ha1-like [KO:K07604]
108289774  KRT37; keratin, type I cuticular Ha7 [KO:K07604]
108289773  KRT9; keratin, type I cytoskeletal 9 [KO:K07604]
108293231  LOW QUALITY PROTEIN: keratin, type I cytoskeletal 19-like [KO:K07604]
108281529  KRT10; keratin, type I cytoskeletal 10 isoform X2 [KO:K07604]
108281530  KRT24; keratin, type I cytoskeletal 24 [KO:K07604]
108281531  KRT28; keratin, type I cytoskeletal 28 isoform X1 [KO:K07604]
108281532  KRT26; keratin, type I cytoskeletal 26 [KO:K07604]
108281533  KRT27; keratin, type I cytoskeletal 27 [KO:K07604]
108281534  KRT25; keratin, type I cytoskeletal 25 [KO:K07604]
108281535  KRT12; keratin, type I cytoskeletal 12 [KO:K07604]
108281538  KRT23; keratin, type I cytoskeletal 23 [KO:K07604]
108281542  KRT40; keratin, type I cytoskeletal 40 [KO:K07604]
108281558  KRT20; keratin, type I cytoskeletal 20 [KO:K07604]
108289857  KRT16; keratin, type I cytoskeletal 16 isoform X1 [KO:K07604]
108289858  KRT36; keratin, type I cuticular Ha6 [KO:K07604]
108289859  keratin, type I cytoskeletal 14 isoform X1 [KO:K07604]
108289860  KRT15; keratin, type I cytoskeletal 15 [KO:K07604]
108289861  KRT38; keratin, type I cuticular Ha8 [KO:K07604]
108289862  KRT32; keratin, type I cuticular Ha2 [KO:K07604]
108289863  KRT13; keratin, type I cytoskeletal 13 [KO:K07604]
108289864  KRT17; keratin, type I cytoskeletal 17 [KO:K07604]
108289865  KRT19; keratin, type I cytoskeletal 19 [KO:K07604]
108289867  KRT35; keratin, type I cuticular Ha5 [KO:K07604]
108289869  keratin, type I cuticular Ha4 isoform X1 [KO:K07604]
108308592  keratin, type I cytoskeletal 18 [KO:K07604]
108282788  FGG; fibrinogen gamma chain isoform X2 [KO:K03905]
108304218  C3; complement C3 isoform X1 [KO:K03990]
108299810  CFB; complement factor B isoform X1 [KO:K01335] [EC:3.4.21.47]
108293137  CFD; complement factor D [KO:K01334] [EC:3.4.21.46]
108298607  complement factor H-like [KO:K04004]
108309814  MBL2; mannose-binding protein C [KO:K03991]
108281422  mannose-binding protein A-like isoform X1 [KO:K03991]
108318507  MASP1; mannan-binding lectin serine protease 1 isoform X1 [KO:K03992] [EC:3.4.21.-]
108286264  MASP2; mannan-binding lectin serine protease 2 isoform X1 [KO:K03993] [EC:3.4.21.104]
108308622  C1QA; complement C1q subcomponent subunit A [KO:K03986]
108308624  C1QB; complement C1q subcomponent subunit B [KO:K03987]
108308623  C1QC; complement C1q subcomponent subunit C [KO:K03988]
108295009  C1R; complement C1r subcomponent [KO:K01330] [EC:3.4.21.41]
108295012  C1S; complement C1s subcomponent [KO:K01331] [EC:3.4.21.42]
108299811  C2; complement C2 [KO:K01332] [EC:3.4.21.43]
108299806  C4A; complement C4-A isoform X1 [KO:K03989]
108285847  C5; complement C5 [KO:K03994]
108291845  C3AR1; C3a anaphylatoxin chemotactic receptor [KO:K04009]
108283846  C5AR1; C5a anaphylatoxin chemotactic receptor 1 isoform X1 [KO:K04010]
108297700  LOW QUALITY PROTEIN: high affinity immunoglobulin gamma Fc receptor IB [KO:K06498]
108316383  FCGR1A; high affinity immunoglobulin gamma Fc receptor I [KO:K06498]
108293619  FCGR2A; low affinity immunoglobulin gamma Fc region receptor II-a isoform X1 [KO:K06472]
108302361  low affinity immunoglobulin gamma Fc region receptor II-c-like [KO:K12560]
108293620  FCGR2B; low affinity immunoglobulin gamma Fc region receptor II-b isoform X1 [KO:K12560]
108293621  FCGR3A; low affinity immunoglobulin gamma Fc region receptor III-A isoform X1 [KO:K06463]
119473862  FCAR; immunoglobulin alpha Fc receptor isoform X1 [KO:K06513]
108286244  FPR3; N-formyl peptide receptor 3 [KO:K04173]
108286245  FPR2; N-formyl peptide receptor 2 [KO:K04173]
108286242  FPR1; LOW QUALITY PROTEIN: fMet-Leu-Phe receptor [KO:K04172]
108310836  PLG; plasminogen isoform X1 [KO:K01315] [EC:3.4.21.7]
108289939  CFI; complement factor I isoform X1 [KO:K01333] [EC:3.4.21.45]
108313040  SELPLG; P-selectin glycoprotein ligand 1 isoform X1 [KO:K06544]
108308341  P-selectin isoform X1 [KO:K06496]
108283590  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
108293872  ITGAL; LOW QUALITY PROTEIN: integrin alpha-L [KO:K05718]
108293916  ITGAM; integrin alpha-M isoform X1 [KO:K06461]
108311252  ITGB2; integrin beta-2 [KO:K06464]
108293127  DEFB1; beta-defensin 1 [KO:K23125]
108293110  beta-defensin 4A-like [KO:K21100]
108293117  beta-defensin 4A-like [KO:K21100]
108293111  beta-defensin 103A [KO:K23126]
108298913  theta defensin subunit A-like [KO:K05230]
108298912  theta defensin subunit A-like [KO:K05230]
108293116  neutrophil defensin 4-like [KO:K05230]
108293123  demidefensin-3-like [KO:K05230]
108293124  neutrophil defensin 1-like [KO:K05230]
108293125  defensin-5-like [KO:K05230]
108294082  cathelicidin antimicrobial peptide [KO:K13916]
108282188  DSG1; desmoglein-1 [KO:K07596]
108291083  uncharacterized protein LOC108291083 [KO:K10785]
108291134  uncharacterized protein LOC108291134 [KO:K10785]
108291137  uncharacterized protein LOC108291137 [KO:K10785]
108300065  HLA class II histocompatibility antigen, DP beta 1 chain isoform X1 [KO:K06752]
108300066  HLA class II histocompatibility antigen, DP alpha 1 chain [KO:K06752]
108300070  HLA class II histocompatibility antigen, DO alpha chain [KO:K06752]
108300073  HLA class II histocompatibility antigen, DM alpha chain [KO:K06752]
108300075  HLA class II histocompatibility antigen, DM beta chain [KO:K06752]
108300083  HLA class II histocompatibility antigen, DQ beta 1 chain isoform X1 [KO:K06752]
108300084  HLA class II histocompatibility antigen, DQ beta 1 chain-like isoform X1 [KO:K06752]
108300085  HLA class II histocompatibility antigen, DQ alpha 2 chain [KO:K06752]
108300086  HLA class II histocompatibility antigen, DQ alpha 1 chain [KO:K06752]
108300087  HLA class II histocompatibility antigen, DQ alpha 2 chain-like [KO:K06752]
108300090  HLA class II histocompatibility antigen, DR beta 3 chain isoform X1 [KO:K06752]
108300093  HLA class II histocompatibility antigen, DR alpha chain [KO:K06752]
108300091  HLA class II histocompatibility antigen, DRB1 beta chain [KO:K06752]
119470189  HLA class II histocompatibility antigen, DO beta chain isoform X1 [KO:K06752]
108299883  LOW QUALITY PROTEIN: HLA class II histocompatibility antigen, DQ beta 2 chain-like [KO:K06752]
108308760  PTAFR; platelet-activating factor receptor [KO:K04279]
108302085  IL10; interleukin-10 [KO:K05443]
Compound
C11596  FMLP
C20898  Lipoteichoic acid
Reference
  Authors
Foster TJ
  Title
Colonization and infection of the human host by staphylococci: adhesion, survival and immune evasion.
  Journal
Vet Dermatol 20:456-70 (2009)
DOI:10.1111/j.1365-3164.2009.00825.x
Reference
  Authors
Foster TJ
  Title
Immune evasion by staphylococci.
  Journal
Nat Rev Microbiol 3:948-58 (2005)
DOI:10.1038/nrmicro1289
Reference
  Authors
Laarman A, Milder F, van Strijp J, Rooijakkers S
  Title
Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.
  Journal
J Mol Med 88:115-20 (2010)
DOI:10.1007/s00109-009-0572-y
Reference
  Authors
Rooijakkers SH, van Kessel KP, van Strijp JA
  Title
Staphylococcal innate immune evasion.
  Journal
Trends Microbiol 13:596-601 (2005)
DOI:10.1016/j.tim.2005.10.002
Reference
  Authors
Iwatsuki K, Yamasaki O, Morizane S, Oono T
  Title
Staphylococcal cutaneous infections: invasion, evasion and aggression.
  Journal
J Dermatol Sci 42:203-14 (2006)
DOI:10.1016/j.jdermsci.2006.03.011
Reference
  Authors
Torres BA, Kominsky S, Perrin GQ, Hobeika AC, Johnson HM
  Title
Superantigens: the good, the bad, and the ugly.
  Journal
Exp Biol Med (Maywood) 226:164-76 (2001)
DOI:10.1177/153537020122600303
Reference
  Authors
Atkins KL, Burman JD, Chamberlain ES, Cooper JE, Poutrel B, Bagby S, Jenkins AT, Feil EJ, van den Elsen JM
  Title
S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation.
  Journal
Mol Immunol 45:1600-11 (2008)
DOI:10.1016/j.molimm.2007.10.021
Reference
  Authors
Silverman GJ, Goodyear CS
  Title
Confounding B-cell defences: lessons from a staphylococcal superantigen.
  Journal
Nat Rev Immunol 6:465-75 (2006)
DOI:10.1038/nri1853
Reference
  Authors
Goodyear CS, Silverman GJ
  Title
Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes.
  Journal
Proc Natl Acad Sci U S A 101:11392-7 (2004)
DOI:10.1073/pnas.0404382101
Reference
  Authors
Haupt K, Reuter M, van den Elsen J, Burman J, Halbich S, Richter J, Skerka C, Zipfel PF
  Title
The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b.
  Journal
PLoS Pathog 4:e1000250 (2008)
DOI:10.1371/journal.ppat.1000250
Reference
  Authors
Bokarewa MI, Jin T, Tarkowski A
  Title
Staphylococcus aureus: Staphylokinase.
  Journal
Int J Biochem Cell Biol 38:504-9 (2006)
DOI:10.1016/j.biocel.2005.07.005
Reference
  Authors
Rooijakkers SH, Ruyken M, Roos A, Daha MR, Presanis JS, Sim RB, van Wamel WJ, van Kessel KP, van Strijp JA
  Title
Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.
  Journal
Nat Immunol 6:920-7 (2005)
DOI:10.1038/ni1235
Reference
  Authors
Rooijakkers SH, Wu J, Ruyken M, van Domselaar R, Planken KL, Tzekou A, Ricklin D, Lambris JD, Janssen BJ, van Strijp JA, Gros P
  Title
Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.
  Journal
Nat Immunol 10:721-7 (2009)
DOI:10.1038/ni.1756
Reference
  Authors
Jongerius I, Kohl J, Pandey MK, Ruyken M, van Kessel KP, van Strijp JA, Rooijakkers SH
  Title
Staphylococcal complement evasion by various convertase-blocking molecules.
  Journal
J Exp Med 204:2461-71 (2007)
DOI:10.1084/jem.20070818
Reference
  Authors
Hair PS, Ward MD, Semmes OJ, Foster TJ, Cunnion KM
  Title
Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b.
  Journal
J Infect Dis 198:125-33 (2008)
DOI:10.1086/588825
Reference
  Authors
Higgins J, Loughman A, van Kessel KP, van Strijp JA, Foster TJ
  Title
Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes.
  Journal
FEMS Microbiol Lett 258:290-6 (2006)
DOI:10.1111/j.1574-6968.2006.00229.x
Reference
  Authors
Laursen NS, Gordon N, Hermans S, Lorenz N, Jackson N, Wines B, Spillner E, Christensen JB, Jensen M, Fredslund F, Bjerre M, Sottrup-Jensen L, Fraser JD, Andersen GR
  Title
Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus.
  Journal
Proc Natl Acad Sci U S A 107:3681-6 (2010)
DOI:10.1073/pnas.0910565107
Reference
  Authors
Ramsland PA, Willoughby N, Trist HM, Farrugia W, Hogarth PM, Fraser JD, Wines BD
  Title
Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1.
  Journal
Proc Natl Acad Sci U S A 104:15051-6 (2007)
DOI:10.1073/pnas.0706028104
Reference
  Authors
de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJ, Heezius EC, Poppelier MJ, Van Kessel KP, van Strijp JA
  Title
Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.
  Journal
J Exp Med 199:687-95 (2004)
DOI:10.1084/jem.20031636
Reference
  Authors
Prat C, Bestebroer J, de Haas CJ, van Strijp JA, van Kessel KP
  Title
A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1.
  Journal
J Immunol 177:8017-26 (2006)
DOI:10.4049/jimmunol.177.11.8017
Reference
  Authors
Bestebroer J, Poppelier MJ, Ulfman LH, Lenting PJ, Denis CV, van Kessel KP, van Strijp JA, de Haas CJ
  Title
Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling.
  Journal
Blood 109:2936-43 (2007)
DOI:10.1182/blood-2006-06-015461
Reference
  Authors
Chung MC, Wines BD, Baker H, Langley RJ, Baker EN, Fraser JD
  Title
The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition.
  Journal
Mol Microbiol 66:1342-55 (2007)
DOI:10.1111/j.1365-2958.2007.05989.x
Reference
  Authors
Chavakis T, Hussain M, Kanse SM, Peters G, Bretzel RG, Flock JI, Herrmann M, Preissner KT
  Title
Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes.
  Journal
Nat Med 8:687-93 (2002)
DOI:10.1038/nm728
Reference
  Authors
Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE, Otto M
  Title
Gram-positive three-component antimicrobial peptide-sensing system.
  Journal
Proc Natl Acad Sci U S A 104:9469-74 (2007)
DOI:10.1073/pnas.0702159104
Reference
  Authors
Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J
  Title
Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases.
  Journal
Antimicrob Agents Chemother 48:4673-9 (2004)
DOI:10.1128/AAC.48.12.4673-4679.2004
Reference
  Authors
Fraser JD, Proft T
  Title
The bacterial superantigen and superantigen-like proteins.
  Journal
Immunol Rev 225:226-43 (2008)
DOI:10.1111/j.1600-065X.2008.00681.x
Reference
  Authors
Yamaguchi T, Nishifuji K, Sasaki M, Fudaba Y, Aepfelbacher M, Takata T, Ohara M, Komatsuzawa H, Amagai M, Sugai M
  Title
Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B.
  Journal
Infect Immun 70:5835-45 (2002)
DOI:10.1128/IAI.70.10.5835-5845.2002
Reference
  Authors
Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J
  Title
Human beta-defensins.
  Journal
Cell Mol Life Sci 63:1294-313 (2006)
DOI:10.1007/s00018-005-5540-2
Reference
  Authors
Zhang Q, Mousdicas N, Yi Q, Al-Hassani M, Billings SD, Perkins SM, Howard KM, Ishii S, Shimizu T, Travers JB
  Title
Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.
  Journal
J Clin Invest 115:2855-61 (2005)
DOI:10.1172/JCI25429
Reference
  Authors
Lehrer RI
  Title
Primate defensins.
  Journal
Nat Rev Microbiol 2:727-38 (2004)
DOI:10.1038/nrmicro976
Related
pathway
cimi04610  Complement and coagulation cascades
cimi04660  T cell receptor signaling pathway
cimi04662  B cell receptor signaling pathway
KO pathway
ko05150   
LinkDB

DBGET integrated database retrieval system